developing biomarkers and treatments for chronic joint diseases

 
Search
 
 
 « Back |   Home »  News & Reports  »  All news  »  New COMP ELISA Focus letter
 

AnaMar news

New COMP ELISA Focus letter

26 Oct 2011, News
Focus letter 6 - Recent data suggest the existence of different phenotypic subsets of RA at clinical onset and elevated serum COMP levels should be interpreted in relation to this new approach

In recent years, data have been published to suggest that anti-CCP positive and anti-CCP negative RA constitute two different phenotypic manifestations of RA with respect to both clinical prognosis and underlying disease mechanisms.

 

 

To read Focus letter 6, or previous issues, please visit www.compelisa.com

AnaMar News
> Latest News
> Press releases
> Sign up for RSS-feeds
Financial reports
> Annual report 2009
> Annual report 2008
> Annual report 2007
> Annual report 2006
> Annual report 2005
> Annual report 2004
Publications
> Abstract EULAR 2010
> Abstract ACR 2009
> Abstract EULAR 2009
> Abstract ACR 2007
Press images
> People
> Logo
© 2010, AnaMar AB, Kungsportsavenyn 22, SE-411 36, Göteborg, Sweden. Phone: +46 31 732 41 40, Fax: +46 31 732 41 49, info@anamar.com